Skip to content

Analysis of intestinal immune cells in patients with inflammatory bowel disease

Analysis of intestinal immune cells in patients with inflammatory bowel disease - Analysis of intestinal immune cells in patients with inflammatory bowel disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043782
Enrollment
100
Registered
2021-03-29
Start date
2021-03-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

None listed

Sponsors

Okayama University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with inflammatory bowel disease

Exclusion criteria

Exclusion criteria: Women who are pregnant or may be pregnant

Design outcomes

Primary

MeasureTime frame
Clarify the characteristics of refractory patients with inflammatory bowel disease by comparing the lymphocyte composition and cytokine profiles of the intestinal mucosa between refractory patients and other patients

Countries

Japan

Contacts

Public ContactMasaya Iwamuro

Okayama University Hospital Department of Gastroenterology and Hepatology

iwamuromasaya@yahoo.co.jp0862357218

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026